Cooper Companies (COO) News
NASDAQ: COOHealth CareOphthalmic GoodsUSD
54.37+0.07 (+0.13%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
COO news summary
We found 2 recent headlines mentioning Cooper Companies (COO): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, COO is up 0.13% at $54.37. The most recent story, "BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study", was published by Nasdaq on Aug 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Cooper Companies headlines
- BDX Completes PREVENT Trial Enrollment for Phasix Mesh StudyBD concludes PREVENT trial enrollment, advancing Phasix Mesh toward a potential FDA submission for incisional hernia prevention.NasdaqBDX, COO, WST, GMED
- Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy?MDLN is set to report first earnings as a public company, with Prime Vendor growth and brand mix in focus ahead of Q4 results.NasdaqMCK, COO, STAA, MDLN